Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
Journal of Investigative Dermatology Home
Close
  • Home
  • Articles & Issues
    • Back
    • Articles In Press
    • Current Issue
    • List of Issues
    • Meeting Abstracts
    • Supplements
  • Authors
    • Back
    • About Open Access
    • Submit a Manuscript 
    • Welcome, Authors!
    • Information for Authors
    • Information for Authors - PDF Download 
    • Contact the Editorial Office
    • Permissions
  • Reviewers
    • Back
    • Information for Reviewers
    • Reviewer Login 
  • Journal Info
    • Back
    • About the Journal
    • About Open Access
    • Contact the Editorial Office
    • Editorial Board
    • Abstracting/Indexing
    • Access Instructions
    • New Content Alerts
    • Submit a Manuscript 
    • Why Publish in JID?
  • Collections
    • Back
    • Atopic Dermatitis
    • Cover Gallery
    • Itch
    • JAAD / JID Junction
    • Landmarks in Cutaneous Biology
    • Melanoma
    • Methods and Techniques for Skin Research
    • Montagna Symposium on the Biology of Skin
    • Pemphigus and Pemphigoid
    • Progress in Translational Research
    • Psoriasis
    • Resources for Clinical Research in the JID
  • News
    • Back
    • Society/Journal News
  • Advertisers 
  • SID
    • Back
    • SID Member Activation 
    • SID Website 
    • Join SID 
    • Annual Meeting 
    • Academic Industry Partnership 
  • ESDR
    • Back
    • ESDR Website 
    • Join ESDR 
    • Awards 
    • Events 
    • Media 
    • Education 
  • JAAD / JID Junction
  • Companion Titles
    • Back
    • Journal of Investigative Dermatology Symposium Proceedings
    • JID Innovations
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Subscribe
  • Claim
Skip menu
    x

    Filter:

    Filters applied

    • Melanoma
    • Open AccessRemove Open Access filter
    Clear all

    Article Type

    • Research Article16
    • Rapid Communication2
    • Review Article1

    Publication Date

    • Last 5 Years3
    Please choose a date range between 2016 and 2018.

    Author

    • Barnhill, Raymond L2
    • Agraz-Doblas, Antonio1
    • Al-Olabi, Lara1
    • Almaraz, Carmen1
    • Amberg, Nicole1
    • Arbiser, Jack L1
    • Asamaowei, Inemo E1
    • Atherton, David J1
    • Aubert, Hélène1
    • Aubin, François1
    • Ayyoub, Maha1
    • Bagazgoitia, Lorea1
    • Bahrami, Armita1
    • Barbarot, Sébastien1
    • Barrett, Jennifer H1
    • Batzer, Jan1
    • Beltran, Sergi1
    • Bernerd, Françoise1
    • Berry, Jacqueline L1
    • Bishop, D Timothy1
    • Borg, Christophe1
    • Borgogna, Cinzia1
    • Borgognoni, Lorenzo1
    • Botchkarev, Vladimir A1
    • Bourrat, Emmanuelle1

    Journal

    • Journal of Investigative Dermatology19

    Keyword

    • siRNA3
    • small interfering RNA3
    • WT3
    • AK2
    • CI2
    • ERK2
    • hair follicle2
    • HF2
    • IF2
    • IFE2
    • interfollicular epidermis2
    • ROS2
    • 25(OH)D1
    • 25-hydroxyvitamin D1
    • 2°HG1
    • 7-AAD1
    • 7-amino actinomycin D1
    • 8-oxo-deoxy-guanine1
    • 8-oxo-dGTP1
    • ALDH1
    • AUC1
    • Bmp1
    • Bu1
    • CAM1
    • CARD1

    Access Filter

      Melanoma

      19 Results
      Subscribe to collection
      • Export
        • PDF
        • Citation

      Please select at least one article in order to proceed.

      Ok
      FilterHide Filter
      • Original Article Melanocytes/Melanoma
        Open Access

        Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based Studies

        Journal of Investigative Dermatology
        Vol. 138Issue 12p2617–2624Published online: June 8, 2018
        • Anne E. Cust
        • Martin Drummond
        • Peter A. Kanetsky
        • Australian Melanoma Family Study Investigators
        • Leeds Case-Control Study Investigators
        • Alisa M. Goldstein
        • and others
        Cited in Scopus: 34
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          It is unclear to what degree genomic and traditional (phenotypic and environmental) risk factors overlap in their prediction of melanoma risk. We evaluated the incremental contribution of common genomic variants (in pigmentation, nevus, and other pathways) and their overlap with traditional risk factors, using data from two population-based case-control studies from Australia (n = 1,035) and the United Kingdom (n = 1,460) that used the same questionnaires. Polygenic risk scores were derived from 21 gene regions associated with melanoma and odds ratios from published meta-analyses.
        • Original Article Photobiology
          Open Access

          Fractional Sunburn Threshold UVR Doses Generate Equivalent Vitamin D and DNA Damage in Skin Types I–VI but with Epidermal DNA Damage Gradient Correlated to Skin Darkness

          Journal of Investigative Dermatology
          Vol. 138Issue 10p2244–2252Published online: May 3, 2018
          • Barbara B. Shih
          • Mark D. Farrar
          • Marcus S. Cooke
          • Joanne Osman
          • Abigail K. Langton
          • Richard Kift
          • and others
          Cited in Scopus: 37
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            Public health guidance recommends limiting sun exposure to sub-sunburn levels, but it is unknown whether these can gain vitamin D (for musculoskeletal health) while avoiding epidermal DNA damage (initiates skin cancer). Well-characterized healthy humans of all skin types (I–VI, lightest to darkest skin) were exposed to a low-dose series of solar simulated UVR of 20%–80% their individual sunburn threshold dose (minimal erythema dose). Significant UVR dose responses were seen for serum 25-hydroxyvitamin D and whole epidermal cyclobutane pyrimidine dimers (CPDs), with as little as 0.2 minimal erythema dose concurrently producing 25-hydroxyvitamin D and CPD.
            Fractional Sunburn Threshold UVR Doses Generate Equivalent Vitamin D and DNA Damage in Skin Types I–VI but with Epidermal DNA Damage Gradient Correlated to Skin Darkness
          • Original Article Melanocytes/Melanoma
            Open Access

            Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase

            Journal of Investigative Dermatology
            Vol. 138Issue 7p1601–1608Published online: February 7, 2018
            • Tobias Mann
            • Wolfram Gerwat
            • Jan Batzer
            • Kerstin Eggers
            • Cathrin Scherner
            • Horst Wenck
            • and others
            Cited in Scopus: 98
            • Preview Hide Preview
            • Download PDF
            • Export Citation
              Tyrosinase is the rate-limiting enzyme of melanin production and, accordingly, is the most prominent target for inhibiting hyperpigmentation. Numerous tyrosinase inhibitors have been identified, but most of those lack clinical efficacy because they were identified using mushroom tyrosinase as the target. Therefore, we used recombinant human tyrosinase to screen a library of 50,000 compounds and compared the active screening hits with well-known whitening ingredients. Hydroquinone and its derivative arbutin only weakly inhibited human tyrosinase with a half-maximal inhibitory concentration (IC50) in the millimolar range, and kojic acid showed a weak efficacy (IC50 > 500 μmol/L).
              Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase
            • Original Article Melanocytes/Melanoma
              Open Access

              Paracrine Activin-A Signaling Promotes Melanoma Growth and Metastasis through Immune Evasion

              Journal of Investigative Dermatology
              Vol. 137Issue 12p2578–2587Published online: August 25, 2017
              • Prudence Donovan
              • Olivier A. Dubey
              • Susanna Kallioinen
              • Katherine W. Rogers
              • Katja Muehlethaler
              • Patrick Müller
              • and others
              Cited in Scopus: 20
              • Preview Hide Preview
              • Download PDF
              • Export Citation
                The secreted growth factor Activin-A of the transforming growth factor β family and its receptors can promote or inhibit several cancer hallmarks including tumor cell proliferation and differentiation, vascularization, lymphangiogenesis and inflammation. However, a role in immune evasion and its relationship with tumor-induced muscle wasting and tumor vascularization, and the relative contributions of autocrine versus paracrine Activin signaling remain to be evaluated. To address this, we compared the effects of truncated soluble Activin receptor IIB as a ligand trap, or constitutively active mutant type IB receptor versus secreted Activin-A or the related ligand Nodal in mouse and human melanoma cell lines and tumor grafts.
                Paracrine Activin-A Signaling Promotes Melanoma Growth and Metastasis through Immune Evasion
              • Original Article Melanocytes/Melanoma
                Open Access

                Melanocytes Sense Blue Light and Regulate Pigmentation through Opsin-3

                Journal of Investigative Dermatology
                Vol. 138Issue 1p171–178Published online: August 22, 2017
                • Claire Regazzetti
                • Laura Sormani
                • Delphine Debayle
                • Françoise Bernerd
                • Meri K. Tulic
                • Gian Marco De Donatis
                • and others
                Cited in Scopus: 162
                • Preview Hide Preview
                • Download PDF
                • Export Citation
                  The shorter wavelengths of the visible light spectrum have been recently reported to induce a long-lasting hyperpigmentation but only in melano-competent individuals. Here, we provide evidence showing that OPN3 is the key sensor in melanocytes responsible for hyperpigmentation induced by the shorter wavelengths of visible light. The melanogenesis induced through OPN3 is calcium dependent and further activates CAMKII followed by CREB, extracellular signal-regulated kinase, and p38, leading to the phosphorylation of MITF and ultimately to the increase of the melanogenesis enzymes: tyrosinase and dopachrome tautomerase.
                  Melanocytes Sense Blue Light and Regulate Pigmentation through Opsin-3
                • Original Article Tumor Biology
                  Open Access

                  HPV8 Field Cancerization in a Transgenic Mouse Model Is due to Lrig1+ Keratinocyte Stem Cell Expansion

                  Journal of Investigative Dermatology
                  Vol. 137Issue 10p2208–2216Published online: June 5, 2017
                  • Simone Lanfredini
                  • Carlotta Olivero
                  • Cinzia Borgogna
                  • Federica Calati
                  • Kathryn Powell
                  • Kelli-Jo Davies
                  • and others
                  Cited in Scopus: 22
                  • Preview Hide Preview
                  • Download PDF
                  • Export Citation
                    β-Human papillomaviruses (HPVs) cause near ubiquitous latent skin infection within long-lived hair follicle (HF) keratinocyte stem cells. In patients with epidermodysplasia verruciformis, β-HPV viral replication is associated with skin keratosis and cutaneous squamous cell carcinoma. To determine the role of HF keratinocyte stem cells in β-HPV-induced skin carcinogenesis, we utilized a transgenic mouse model in which the keratin 14 promoter drives expression of the entire HPV8 early region (HPV8tg).
                    HPV8 Field Cancerization in a Transgenic Mouse Model Is due to Lrig1+ Keratinocyte Stem Cell Expansion
                  • Original Article Keratinocytes/Epidermis
                    Open Access

                    p63 Transcription Factor Regulates Nuclear Shape and Expression of Nuclear Envelope-Associated Genes in Epidermal Keratinocytes

                    Journal of Investigative Dermatology
                    Vol. 137Issue 10p2157–2167Published online: June 5, 2017
                    • Valentina Rapisarda
                    • Igor Malashchuk
                    • Inemo E. Asamaowei
                    • Krzysztof Poterlowicz
                    • Michael Y. Fessing
                    • Andrey A. Sharov
                    • and others
                    Cited in Scopus: 18
                    • Preview Hide Preview
                    • Download PDF
                    • Export Citation
                      The maintenance of a proper nuclear architecture and three-dimensional organization of the genes, enhancer elements, and transcription machinery plays an essential role in tissue development and regeneration. Here we show that in the developing skin, epidermal progenitor cells of mice lacking p63 transcription factor display alterations in the nuclear shape accompanied by a marked decrease in expression of several nuclear envelope-associated components (Lamin B1, Lamin A/C, Sun1, Nesprin-3, Plectin) compared with controls.
                      p63 Transcription Factor Regulates Nuclear Shape and Expression of Nuclear Envelope-Associated Genes in Epidermal Keratinocytes
                    • Original Article Tumor Biology
                      Open Access

                      Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas

                      Journal of Investigative Dermatology
                      Vol. 137Issue 1p197–206Published online: September 1, 2016
                      • María del Carmen González-Vela
                      • Soraya Curiel-Olmo
                      • Sophia Derdak
                      • Sergi Beltran
                      • Miguel Santibañez
                      • Nerea Martínez
                      • and others
                      Cited in Scopus: 61
                      • Preview Hide Preview
                      • Download PDF
                      • Export Citation
                        Merkel cell carcinoma (MCC) is a highly malignant neuroendocrine tumor of the skin whose molecular pathogenesis is not completely understood, despite the role that Merkel cell polyomavirus can play in 55–90% of cases. To study potential mechanisms driving this disease in clinically characterized cases, we searched for somatic mutations using whole-exome sequencing, and extrapolated our findings to study functional biomarkers reporting on the activity of the mutated pathways. Confirming previous results, Merkel cell polyomavirus-negative tumors had higher mutational loads with UV signatures and more frequent mutations in TP53 and RB compared with their Merkel cell polyomavirus-positive counterparts.
                        Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas
                      • Original Article Melanocytes/Melanoma
                        Open Access

                        Reactive Oxygen Species Dictate the Apoptotic Response of Melanoma Cells to TH588

                        Journal of Investigative Dermatology
                        Vol. 136Issue 11p2277–2286Published online: July 14, 2016
                        • Jia Yu Wang
                        • Lei Jin
                        • Xu Guang Yan
                        • Simonne Sherwin
                        • Margaret Farrelly
                        • Yuan Yuan Zhang
                        • and others
                        Cited in Scopus: 31
                        • Preview Hide Preview
                        • Download PDF
                        • Export Citation
                          The effect of MTH1 inhibition on cancer cell survival has been elusive. Here we report that although silencing of MTH1 does not affect survival of melanoma cells, TH588, one of the first-in-class MTH1 inhibitors, kills melanoma cells through apoptosis independently of its inhibitory effect on MTH1. Induction of apoptosis by TH588 was not alleviated by MTH1 overexpression or introduction of the bacterial homolog of MTH1 that has 8-oxodGTPase activity but cannot be inhibited by TH588, indicating that MTH1 inhibition is not the cause of TH588-induced killing of melanoma cells.
                          Reactive Oxygen Species Dictate the Apoptotic Response of Melanoma Cells to TH588
                        • Original Article Appendages
                          Open Access

                          Effects of Imiquimod on Hair Follicle Stem Cells and Hair Cycle Progression

                          Journal of Investigative Dermatology
                          Vol. 136Issue 11p2140–2149Published online: July 1, 2016
                          • Nicole Amberg
                          • Martin Holcmann
                          • Gabriel Stulnig
                          • Maria Sibilia
                          Cited in Scopus: 24
                          • Preview Hide Preview
                          • Download PDF
                          • Export Citation
                            Topical imiquimod (IMQ) application is widely used as a model for psoriasiform-like skin inflammation in mice. Although the effects on the epidermis are well characterized, it is unclear how IMQ affects hair follicles and cycling. Here we investigated how IMQ affects hair follicle stem cells and whether the timing of IMQ application influences the immune infiltrate. Our results show that IMQ application at mid and late telogen activated hair follicle stem cells leading to premature hair cycle entry (anagen), which was accompanied by massive infiltration of inflammatory macrophages and gamma delta T cells, whereas the number of the respective resident populations decreased.
                            Effects of Imiquimod on Hair Follicle Stem Cells and Hair Cycle Progression
                          • Original Article Melanocytes/Melanoma
                            Open Access

                            Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival

                            Journal of Investigative Dermatology
                            Vol. 136Issue 10p2059–2069Published online: June 29, 2016
                            • Silvia Pietrobono
                            • Andrea Morandi
                            • Sinforosa Gagliardi
                            • Gianni Gerlini
                            • Lorenzo Borgognoni
                            • Paola Chiarugi
                            • and others
                            Cited in Scopus: 26
                            • Preview Hide Preview
                            • Download PDF
                            • Export Citation
                              Human melanomas contain a population of tumor-initiating cells that are able to maintain the growth of the tumor. We previously showed that the embryonic transcription factor SOX2 is essential for self-renewal and tumorigenicity of human melanoma-initiating cells. However, targeting a transcription factor is still challenging. Gentian violet (GV) is a cationic triphenylmethane dye with potent antifungal and antibacterial activity. Recently, a combination therapy of imiquimod and GV has shown an inhibitory effect against melanoma metastases.
                              Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival
                            • Letter to the Editor
                              Open Access

                              Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities

                              Journal of Investigative Dermatology
                              Vol. 136Issue 12p2502–2505Published online: June 23, 2016
                              • Martin Lauss
                              • Jeremie Nsengimana
                              • Johan Staaf
                              • Julia Newton-Bishop
                              • Göran Jönsson
                              Cited in Scopus: 20
                              • Preview Hide Preview
                              • Download PDF
                              • Export Citation
                                Identification of recurrent mutation in the BRAF oncogene in melanoma has led to the development of highly selective kinase inhibitors (Larkin et al., 2014). Although dramatic treatment responses are initially observed, responses are rarely durable. The mutational classification based on BRAF, NRAS, and NF1 mutations that has been established, however, is nonoverlapping with classification derived from gene expression profiling (The Cancer Genome Atlas Network [TCGA], 2015; Jönsson et al., 2010).
                                Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities
                              • Original Article Tumor Biology
                                Open Access

                                Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity

                                Journal of Investigative Dermatology
                                Vol. 136Issue 8p1701–1710Published online: April 2, 2016
                                • Minna Piipponen
                                • Liisa Nissinen
                                • Mehdi Farshchian
                                • Pilvi Riihilä
                                • Atte Kivisaari
                                • Markku Kallajoki
                                • and others
                                Cited in Scopus: 51
                                • Preview Hide Preview
                                • Download PDF
                                • Export Citation
                                  Keratinocyte-derived cutaneous squamous cell carcinoma (cSCC) is the most common metastatic skin cancer, and its incidence is increasing globally. Long noncoding RNAs (lncRNA) are involved in various biological processes, and their role in cancer progression is emerging. Whole transcriptome analysis of cSCC cells (n = 8) and normal human epidermal keratinocytes (n = 4) revealed overexpression of long intergenic ncRNA (LINC00162) in cSCC cells. The expression of LINC00162 in cSCC cells was upregulated by inhibition of the p38α and p38δ mitogen-activated protein kinases.
                                  Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity
                                • Original Article Tumor Biology
                                  Open Access

                                  Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome

                                  Journal of Investigative Dermatology
                                  Vol. 136Issue 7p1490–1499Published online: March 30, 2016
                                  • Aparna Prasad
                                  • Raquel Rabionet
                                  • Blanca Espinet
                                  • Luis Zapata
                                  • Anna Puiggros
                                  • Carme Melero
                                  • and others
                                  Cited in Scopus: 60
                                  • Preview Hide Preview
                                  • Download PDF
                                  • Export Citation
                                    Sézary syndrome is a leukemic form of cutaneous T-cell lymphoma with an aggressive clinical course. The genetic etiology of the disease is poorly understood, with chromosomal abnormalities and mutations in some genes being involved in the disease. The goal of our study was to understand the genetic basis of the disease by looking for driver gene mutations and fusion genes in 15 erythrodermic patients with circulating Sézary cells, 14 of them fulfilling the diagnostic criteria of Sézary syndrome.
                                    Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome
                                  • Review
                                    Open Access

                                    The Role of Neutrophilic Inflammation, Angiotropism, and Pericytic Mimicry in Melanoma Progression and Metastasis

                                    Journal of Investigative Dermatology
                                    Vol. 136Issue 2p372–377Published in issue: February, 2016
                                    • Jennifer Landsberg
                                    • Thomas Tüting
                                    • Raymond L. Barnhill
                                    • Claire Lugassy
                                    Cited in Scopus: 19
                                    • Preview Hide Preview
                                    • Download PDF
                                    • Export Citation
                                      Angiotropism in melanoma correlates with ulceration and poor prognosis. It has been shown to be a marker of pericytic mimicry, that is, the spreading of tumor cells in a pericyte location along abluminal vascular surfaces. Such extravascular tumor spread may represent another form of tumor plasticity with reversion to a neural crest cell migratory phenotype. In a murine melanoma model, it has recently been demonstrated that neutrophilic skin inflammation promotes angiotropism and metastatic spread of primary melanomas.
                                      The Role of Neutrophilic Inflammation, Angiotropism, and Pericytic Mimicry in Melanoma Progression and Metastasis
                                    • Original Article Melanocytes/Melanoma
                                      Open Access

                                      Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis

                                      Journal of Investigative Dermatology
                                      Vol. 136Issue 5p994–1001Published online: January 29, 2016
                                      • Nicolas Jacquelot
                                      • María Paula Roberti
                                      • David P. Enot
                                      • Sylvie Rusakiewicz
                                      • Michaela Semeraro
                                      • Sarah Jégou
                                      • and others
                                      Cited in Scopus: 24
                                      • Preview Hide Preview
                                      • Download PDF
                                      • Export Citation
                                        Stage III metastatic melanomas require adequate adjuvant immunotherapy to prevent relapses. Prognostic factors are awaited to optimize the clinical management of these patients. The magnitude of metastatic lymph node invasion and the BRAFV600 activating mutation have clinical significance. Based on a comprehensive immunophenotyping of 252 parameters per patient in paired blood and metastatic lymph nodes performed in 39 metastatic melanomas, we found that blood markers were as contributive as tumor-infiltrated lymphocyte immunotypes, and parameters associated with lymphocyte exhaustion/suppression showed higher clinical significance than those related to activation or lineage.
                                        Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis
                                      • Original Article Genetics
                                        Open Access

                                        Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis

                                        Journal of Investigative Dermatology
                                        Vol. 136Issue 4p770–778Published online: January 14, 2016
                                        • Anna C. Thomas
                                        • Zhiqiang Zeng
                                        • Jean-Baptiste Rivière
                                        • Ryan O’Shaughnessy
                                        • Lara Al-Olabi
                                        • Judith St.-Onge
                                        • and others
                                        Cited in Scopus: 114
                                        • Preview Hide Preview
                                        • Download PDF
                                        • Export Citation
                                          Common birthmarks can be an indicator of underlying genetic disease but are often overlooked. Mongolian blue spots (dermal melanocytosis) are usually localized and transient, but they can be extensive, permanent, and associated with extracutaneous abnormalities. Co-occurrence with vascular birthmarks defines a subtype of phakomatosis pigmentovascularis, a group of syndromes associated with neurovascular, ophthalmological, overgrowth, and malignant complications. Here, we discover that extensive dermal melanocytosis and phakomatosis pigmentovascularis are associated with activating mutations in GNA11 and GNAQ, genes that encode Gα subunits of heterotrimeric G proteins.
                                          Mosaic Activating Mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis
                                        • Letter to the Editor
                                          Open Access

                                          Telomerase Expression by Aberrant Methylation of the TERT Promoter in Melanoma Arising in Giant Congenital Nevi

                                          Journal of Investigative Dermatology
                                          Vol. 136Issue 1p339–342Published in issue: January, 2016
                                          • Yiping Fan
                                          • Seungjae Lee
                                          • Gang Wu
                                          • John Easton
                                          • Donald Yergeau
                                          • Reinhard Dummer
                                          • and others
                                          Cited in Scopus: 30
                                          • Preview Hide Preview
                                          • Download PDF
                                          • Export Citation
                                            Telomeres are tandem repeats of the noncoding DNA structures at the end of human chromosomes that protect the coding DNA and the integrity of the genome (Blackburn, 1991). The ability to sustain telomere length confers unlimited proliferative capacity to cancer cells. In most cancers telomere length is maintained by the activity of the enzyme telomerase (Kim et al., 1994), whose catalytic subunit is encoded by the telomerase reverse transcriptase (TERT) gene. However, until recently, the underlying mechanisms for telomerase activation in cancer cells were largely unknown.
                                            Telomerase Expression by Aberrant Methylation of the TERT Promoter in Melanoma Arising in Giant Congenital Nevi
                                          • Original Article Keratinocytes/Epidermis
                                            Open Access

                                            Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation

                                            Journal of Investigative Dermatology
                                            Vol. 136Issue 1p192–201Published in issue: January, 2016
                                            • Nan-Lin Wu
                                            • Duen-Yi Huang
                                            • Li-Fang Wang
                                            • Reiji Kannagi
                                            • Yu-Ching Fan
                                            • Wan-Wan Lin
                                            Cited in Scopus: 23
                                            • Preview Hide Preview
                                            • Download PDF
                                            • Export Citation
                                              Spleen tyrosine kinase (Syk), a nonreceptor tyrosine kinase, was initially identified as a crucial regulator in proximal immunoreceptor signaling. Additional studies have revealed its pleiotropic roles, and drugs targeting Syk are under development for inflammatory diseases. Syk expression in the skin has been detected, but its functions in the skin are still unknown. Here, we found that Syk phosphorylation and expression in primary human keratinocytes decreased gradually along with terminal differentiation.
                                              Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation
                                            Page 1 of 1

                                            Login to your account

                                            Show
                                            Forgot password?
                                            Don’t have an account?
                                            Create a Free Account

                                            If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

                                            If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

                                            Cancel
                                            • Home
                                            • Articles & Issues
                                            • Articles In Press
                                            • Current Issue
                                            • List of Issues
                                            • Meeting Abstracts
                                            • Supplements
                                            • Authors
                                            • About Open Access
                                            • Submit a Manuscript
                                            • Welcome, Authors!
                                            • Information for Authors
                                            • Information for Authors - PDF Download
                                            • Contact
                                            • Permissions
                                            • Reviewers
                                            • Information for Reviewers
                                            • Reviewer Login
                                            • Journal Info
                                            • About the Journal
                                            • About Open Access
                                            • Contact the Editorial Office
                                            • Editorial Board
                                            • Abstracting/Indexing
                                            • Access Instructions
                                            • New Content Alerts
                                            • Submit a Manuscript
                                            • Why Publish in JID?
                                            • Collections
                                            • Atopic Dermatitis
                                            • Cover Gallery
                                            • Itch
                                            • JAAD / JID Junction
                                            • Landmarks in Cutaneous Biology
                                            • Melanoma
                                            • Methods and Techniques for Skin Research
                                            • Montagna Symposium on the Biology of Skin
                                            • Pemphigus & Pemphigoid
                                            • Progress in Translational Research
                                            • Psoriasis
                                            • Resources for Clinical Research in the JID
                                            • News
                                            • Society/Journal News
                                            • Advertisers
                                            • SID
                                            • SID Member Activation
                                            • SID Website
                                            • Join SID
                                            • Annual Meeting
                                            • Academic Industry Partnership
                                            • ESDR
                                            • ESDR Website
                                            • Join ESDR
                                            • Awards
                                            • Events
                                            • Media
                                            • Education
                                            • JAAD / JID Junction - NEW!
                                            • Companion Titles
                                            • Journal of Investigative Dermatology Symposium Proceedings
                                            • JID Innovations
                                            • Follow Us
                                            • Facebook
                                            • Twitter
                                            We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
                                            Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.

                                            • Privacy Policy  
                                            • Terms and Conditions  
                                            • Accessibility  
                                            • Help & Contact

                                            RELX